Cyproheptadine hydrochloride, H1 and 5-HT2B antagonist (ab120732)
Key features and details
- Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist.
- CAS Number: 41354-29-4
- Purity: > 99%
- Soluble in water to 10 mM (with warming) and in DMSO to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Cyproheptadine hydrochloride, H1 and 5-HT2B antagonist -
Description
Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist. -
Biological description
Potent H1 and 5-HT2B antagonist (Ki and pKi values are 10 and 1.4 nM, respectively). Non-selective receptor antagonist (shows high potency (low nM) at other 5-HT, dopamine and muscarinic acetylcholine receptors. Displays antihistaminergic and antiserotonergic effects.
-
Purity
> 99% -
CAS Number
41354-29-4 -
Chemical structure
Properties
-
Chemical name
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidine)methylpiperidine hydrochloride sesquihydrate -
Molecular weight
350.89 -
Molecular formula
C21H21N.HCl.1.5H2O -
Storage instructions
Store at Room Temperature. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 10 mM (with warming) and in DMSO to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
Source
Synthetic
-
Research areas
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (0)
ab120732 has not yet been referenced specifically in any publications.